Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B
Medical Oncology, 10/01/09
Allegra A et al. – This case offers the occasion to emphasize the importance of medium–term and long–term hemovigilance also in other kind of patients than in subjects on immunosuppressive therapy. A deeper follow–up is advisable even in patients showing an unexplainable worsening of their hematological conditions.
Related Articles
Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura
International Journal of Hematology, 10/12/09
Relevance Score: 70%
Immune thrombocytopenia associated with Mycoplasma pneumoniae infection: a case report and review of literature
Blood Coagulation & Fibrinolysis, 10/07/09
Relevance Score: 68%
Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia
International Journal of Hematology, 10/13/09
Relevance Score: 67%
Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura
Blood, 10/02/09
Relevance Score: 67%
Romiplostim in chronic immune thrombocytopenic purpura
Clinical Therapeutics, 10/23/09
Relevance Score: 66%
Today in Coagulation/Bleeding Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Kasabach–Merritt phenomenon: a single centre experience
European Journal of Haematology, 12/10/09
Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies
Best Practice & Research: Clinical Haematology , 12/10/09
Developments in factor Xa inhibitors for the treatment of thromboembolic disorders
Medicinal Research Reviews, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


